representative work

Ramm Pharma Enters European Cannabis Market with Strategic Investment in Canapar Corp.


On December 30, 2020, Ramm Pharma Corp., a leader in plant-derived cannabinoid (CBD) pharmaceutical and other cannabis-based products, completed its acquisition of a 49% interest Canapar Corp. from Canopy Rivers Corp. Canapar is an Italy-based manufacturer and processor of CBD oil and isolates, which are increasingly used as an input into new commercial products in the health and wellness industries.

Cassels represented Ramm Pharma with a deal team including Jay Goldman and David Gardos (Securities and Cannabis) and Luke Woolford (M&A and Cannabis).

RELATED EXPERTISE: Securities | Cannabis | Mergers & Acquisitions